Home › Funds › Nextech Invest Ltd. › KYMR

Nextech Invest Ltd. position in KYMR

KYMERA THERAPEUTICS INC · Health Care

Nextech Invest Ltd. reported holding 278,896 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$32.0M, representing 1.52% of its reported portfolio and ranking #7 among its reported holdings. Nextech Invest Ltd. has disclosed KYMR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)278.90K sh
Reported value held$31.98M
Portfolio Weight1.52%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Nextech Invest Ltd.'s KYMR position evolved

Nextech Invest Ltd. first disclosed a stake in KYMR in Q2 2025 at 340,909 shares (US$14.9M). The position peaked in Q2 2026 at 278,896 shares, worth US$32.0M. Across 5 filings, Nextech Invest Ltd. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 278,896 shares valued at US$32.0M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 340.91K $14.88M New
Q3 2025 340.91K $19.30M Hold
Q4 2025 278.90K $21.70M Reduce
Q1 2026 278.90K $23.23M Hold
Q2 2026 278.90K $31.98M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has Nextech Invest Ltd. held KYMR?

Nextech Invest Ltd. has disclosed KYMR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Nextech Invest Ltd.'s current position in KYMR?

As of Q2 2026, Nextech Invest Ltd. holds 278.90K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $31.98M, representing 1.52% of its reported portfolio and ranking #7.

Has Nextech Invest Ltd. been buying or selling KYMR?

In the latest 13F filing (Q2 2026), Nextech Invest Ltd. held unchanged its position in KYMR. The position peaked in Q2 2026 at 278.90K shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.